24/02/2019 15:45:00

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AXGN, DXC, MAXR and BRS

CEDARHURST, N.Y., Feb. 24, 2019 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

AxoGen, Inc. (NASDAQ: AXGN)

Investors Affected: August 7, 2017 - December 18, 2018

A class action has commenced on behalf of certain shareholders in AxoGen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company aggressively increased prices to mask lower sales; (2) the Company’s pricing alienated customers and threatened the Company’s future growth; (3) ambulatory surgery centers form a significant part of the market for the Company’s products; (4) such centers were especially sensitive to price increases; (5) the Company was dependent on a small number of surgeons whom the Company paid to generate sales; (6) the Company’s consignment model for inventory was reasonably likely to lead to channel stuffing; (7) the Company offered purchase incentives to sales representatives to encourage channel stuffing; (8) the Company’s sales representatives were encouraged to backdate revenue to artificially inflate metrics; (9) the Company lacked adequate internal controls to prevent such channel stuffing and backdating of revenue; (10) the Company’s key operating metrics, such as number of active accounts, were overstated; and (11) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kseclaw.com/securities/axogen-inc/?wire=3

DXC Technology Company (NYSE: DXC)

Investors Affected: February 8, 2018 - November 6, 2018

A class action has commenced on behalf of certain shareholders in DXC Technology Company. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had changed or planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that were better capable of delivering specialized services to its clients; (b) the Company’s workforce optimization strategy of sharply reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services, thereby risking and ultimately losing sales and revenue opportunities; (c) in light of the above, the Company’s revenue and financial performance guidance for the fiscal year 2019 and its reaffirmation of the guidance during the Class Period was without a reasonable basis.

Shareholders may find more information at https://kseclaw.com/securities/dxc-technology-company/?wire=3

Maxar Technologies Inc. (NYSE: MAXR)

Investors Affected: March 29, 2018 - January 7, 2019

A class action has commenced on behalf of certain shareholders in Maxar Technologies Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (ii) Maxar’s highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://kseclaw.com/securities/maxar-technologies-inc/?wire=3

Bristow Group Inc. (NYSE: BRS)

Investors Affected: February 8, 2018 - February 12, 2019

A class action has commenced on behalf of certain shareholders in Bristow Group Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Bristow lacked adequate monitoring processes related to non-financial covenants within its secured financing and lease agreements; (2) Bristow could not reasonably assure compliance with certain non-financial covenants; (3) Bristow was reasonably likely to breach certain agreements; (4) Bristow had understated its short-term debt; (5) the required corrections would materially impact financial statements; (6) there was a material weakness in Bristow’s internal controls over financial reporting; and (7) as a result of the foregoing, defendants’ positive statements about Bristow’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/bristow-group-inc-loss-submission-form/?wire=3

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock.

CONTACT:

Kuznicki Law PLLC

Daniel Kuznicki, Esq.

445 Central Avenue, Suite 334

Cedarhurst, NY 11516

Email: dk@kclasslaw.com

Phone: (347) 696-1134

Cell: (347) 690-0692

Fax: (347) 348-0967

KUZNICKI (002).png

Related content
19 Jul - 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an I..
27 Jun - 
DXC Technology and Zafin Partner to Help Banks Manage C..
27 Jun - 
DXC Technology and Zafin Partner to Help Banks Manage C..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Issue of Equity
2
Transaction in Own Shares
3
End of Day
4
Issue of Equity
5
Issue of Equity

Related stock quotes

AxoGen Inc 18.75 -0.3% Stock price decreasing
DXC Technology Company 56.72 0.8% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 July 2019 23:52:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB2 - 2019-07-24 00:52:12 - 2019-07-23 23:52:12 - 1000 - Website: OKAY